| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.07B | 1.39B | 1.56B | 1.93B | 2.76B | 2.49B |
| Gross Profit | 245.56M | 272.55M | 295.84M | 427.37M | 606.04M | 550.37M |
| EBITDA | -125.12M | -236.85M | -244.91M | -11.89M | 147.06M | 133.69M |
| Net Income | -145.00M | -258.80M | -307.84M | -35.24M | 108.55M | 52.24M |
Balance Sheet | ||||||
| Total Assets | 414.38M | 401.95M | 635.82M | 878.55M | 1.07B | 830.21M |
| Cash, Cash Equivalents and Short-Term Investments | 167.37M | 159.17M | 302.61M | 371.26M | 503.34M | 496.62M |
| Total Debt | 24.77M | 32.66M | 3.75M | 42.51M | 51.35M | 59.69M |
| Total Liabilities | 211.44M | 239.22M | 276.69M | 232.72M | 321.58M | 393.89M |
| Stockholders Equity | 202.60M | 162.73M | 359.13M | 645.83M | 744.39M | 373.69M |
Cash Flow | ||||||
| Free Cash Flow | -95.35M | -194.66M | -63.58M | -1.32B | -336.33M | 181.60M |
| Operating Cash Flow | -71.89M | -174.30M | -18.59M | -990.98M | 17.85M | 196.47M |
| Investing Cash Flow | 1.06M | 24.93M | -44.63M | -298.74M | -349.18M | -23.55M |
| Financing Cash Flow | 123.75M | 32.72M | -5.49M | 967.03M | -606.02M | 231.36M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $24.67B | 22.72 | 56.92% | 1.37% | 5.10% | 7.59% | |
72 Outperform | $6.15B | 20.26 | 20.83% | 3.10% | 13.37% | -19.37% | |
67 Neutral | $3.75B | 10.26 | 18.34% | 1.04% | -0.65% | -10.35% | |
62 Neutral | $13.97B | 22.01 | 22.49% | 5.46% | -0.95% | -48.28% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
58 Neutral | $14.94B | -44.78 | ― | ― | 3.35% | 42.99% | |
45 Neutral | $469.55M | -2.43 | -72.72% | ― | -27.23% | 62.19% |
On January 9, 2026, Bed Bath & Beyond purchased an additional $2.17 million participation in term loans issued by The Container Store under an existing credit agreement, following an earlier $6.46 million loan participation made on November 25, 2025. Together, these transactions increased the company’s exposure to The Container Store’s debt and entitle Bed Bath & Beyond to interest and principal repayments and associated enforcement rights, signaling a deeper financial involvement with another specialty retailer that could affect its investment profile and risk-return dynamics.
The most recent analyst rating on (BBBY) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on Bed Bath & Beyond stock, see the BBBY Stock Forecast page.
On December 30, 2025, Bed Bath & Beyond’s board appointed Executive Chairman and principal executive officer Marcus Lemonis as Chief Executive Officer, effective January 1, 2026, consolidating the company’s top leadership roles under a single executive as it finalizes his employment agreement. Concurrently, the employment of Chief Operating Officer and principal operating officer Alexander Thomas was terminated on January 1, 2026, though he is expected to remain as an advisor during a transition period to support continuity in operations and leadership change management.
The most recent analyst rating on (BBBY) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Bed Bath & Beyond stock, see the BBBY Stock Forecast page.
On November 25, 2025, Bed Bath & Beyond, Inc. acquired a portion of loans from The Container Store, Inc. through a participation agreement. This transaction, valued at $6,461,843.09, allows the company to gain rights to interest payments and loan repayments, potentially impacting its financial operations and stakeholder interests.
The most recent analyst rating on (BBBY) stock is a Sell with a $6.00 price target. To see the full list of analyst forecasts on Bed Bath & Beyond stock, see the BBBY Stock Forecast page.
On November 24, 2025, Bed Bath & Beyond, Inc. announced a merger agreement with The Brand House Collective, Inc., where TBHC will become a wholly owned subsidiary. The merger involves an exchange of shares and is subject to customary conditions, including shareholder approval and regulatory compliance. Additionally, Bed Bath & Beyond has amended its credit agreement to increase its loan commitments by $10 million, indicating a strategic financial maneuver to support the merger and future operations.
The most recent analyst rating on (BBBY) stock is a Sell with a $6.00 price target. To see the full list of analyst forecasts on Bed Bath & Beyond stock, see the BBBY Stock Forecast page.
On November 14, 2025, Bed Bath & Beyond‘s board of directors approved the 2025 Employment Inducement Equity Incentive Plan, allowing the issuance of up to 1,500,000 shares of common stock as equity-based awards to eligible recipients. This plan, adopted without stockholder approval under NYSE Rule 303A.08, aims to attract and retain employees by offering stock options and other incentives, potentially impacting the company’s talent acquisition and retention strategies.
The most recent analyst rating on (BBBY) stock is a Sell with a $6.00 price target. To see the full list of analyst forecasts on Bed Bath & Beyond stock, see the BBBY Stock Forecast page.